MassChallenge

Aseptuva is an early-stage MedTech startup located in Technopark Winterthur, dedicated to addressing Healthcare-Associated Infections (HAI) that arise from catheter use in healthcare facilities. Catheters, essential for delivering medications, are often contaminated with pathogens, leading to severe complications such as pneumonia and bloodstream infections, which result in significant mortality and substantial healthcare costs. To combat this issue, Aseptuva is developing innovative medical devices designed for in-situ disinfection of various catheters, aiming to prevent infections before they occur. The company’s technology offers a robust automated system that assists medical staff, ultimately helping hospitals reduce the incidence of infections and save lives. Aseptuva aspires to establish a new standard in critical care, positively influencing millions of patients worldwide.

HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.

Born Maverick is a plant-based food startup founded in the UK.

ALPHS is a fast-growing privately held organization with a business valuation of $7 million as of 2023, Forbes estimated. The inspirational success story of the empire redirects to Ashini Gogoi, an ex-Meta employee, who haphazardly started it as a lifestyle community on Instagram in January 2021 as per an investigation by CNN—Forbes declared that he is a young yet enigmatic self-made CEO. Following his vision in August 2020, Ashini managed to take a loan capital of US$40,000 from his friends and family, his company started making headlines in major publications for the first time in November 2022, when the company signed a contract with the American rapper, Wiz Khalifa. The company is listed as a high-profile organization on Crunchbase and is actively offering its services in Tier 1 countries as of 2023—a statistical analysis showed that 87% of its customer base is women from the United States, United Kingdom, Canada, Australia, New Zealand, and Italy. The company's website gets active during major festivals only and consumers can purchase for a limited duration of seven days, hence selling out very quickly—their most affordable models that hold their value start between $850 and $1,200. "ALPHS Inc. is one of the most secretive young companies in corporate history next to the giant Rolex," says the American business newspaper, The Wall Street Journal. Reports suggest that Ashini took down several notable articles including Forbes, CNN, WSJ—while his organization was under suspicion by April 2023—the company claimed that their products were meticulously made and they had consistently maintained their values. The company has drawn criticism from multiple sources, with questions raised about its secretive nature, and faced numerous allegations on whether their business was legal—including a handful of law firms in the financial investigation—a rigorous background check was done which publicized that they operate as an online retailer—with the approval of the Jewelers Vigilance Committee—the materials used by the company were declared legitimate in October 2022. The company also produces high-quality films titled, "Inspired by best-selling novels" for customer retention and is investing enormous funds in the development of artificial intelligence. ALPHS headquarters were officially shifted from Hyderabad, India to Milan, Italy in March 2023 under the guidance of Y Combinator, the lead investor of the company. As of 2023, the company has reportedly signed agreements with eleven prominent stars and models for endorsing its products.

Selmod, based in Basel, Switzerland, specializes in developing innovative therapies aimed at treating life-threatening, multi-drug resistant infections. The company focuses on discovering and advancing small molecules and peptides that target new mechanisms of action, addressing the urgent need for effective treatments in hospital settings where first-line therapies have failed. Selmod aims to provide second-line and last-resort options through a disruptive approach that incorporates dual modes of action to overcome resistance mechanisms. The company's lead candidates, SLM500, SLM100, and SLM300, have shown promise in preclinical studies, with market projections indicating a total available market exceeding $9 billion. With an experienced leadership team skilled in advancing clinical candidates for major pharmaceutical companies, Selmod plans to utilize funding to advance three IND-enabling candidates and six lead-optimized candidates into proof-of-concept stages.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.

NaturLoop is a Swiss-based cleantech and material science company focused on sustainable development through the production of natural biocomposites. The company specializes in manufacturing coconut-based fiberboard made from agricultural and agroforestry waste, utilizing a low-tech process that promotes circular economy practices. NaturLoop's innovative approach not only addresses environmental concerns but also aims to provide affordable and accessible sustainable materials for the construction sector. By leveraging existing wood panel infrastructure, NaturLoop offers a versatile and eco-friendly alternative to expensive imported building materials. Additionally, the company emphasizes community involvement, integrating local rural communities into its value chain while developing commercially viable products that help mitigate the depletion of natural resources.

Eaternity AG is a software management company based in Zurich, Switzerland, that specializes in the restaurant industry. Founded in 2014 by Judith Ellens and Manuel Klarmann at ETH Zurich, Eaternity provides a platform that offers a real-time calculation engine for addressing allergen and nutrition declarations, as well as assessing the carbon footprint of meals and restaurants. The company's solutions enable restaurant owners to gain valuable insights into their supply chain, facilitating informed decision-making. Eaternity also aims to support organizations globally in calculating the environmental impact of their food products, striving for a sustainable food system within the planet's ecological boundaries. Through its Eaternity Score, the company transparently communicates the environmental effects of various food products, serving both consumers and decision-makers.

Oxyle AG is a Swiss company based in Zurich that specializes in wastewater treatment aimed at removing persistent and toxic micropollutants from water sources. Established in 2020, the company has developed a novel technology that effectively degrades hazardous substances, including pharmaceuticals, personal-care products, endocrine-disrupting chemicals, pesticides, and industrial chemicals. Oxyle serves a diverse clientele, including the pharmaceutical, biotech, chemical, food and beverage sectors, research laboratories, hospitals, and wastewater treatment facilities. Its innovative approach not only helps clients comply with regulatory standards but also offers a sustainable alternative to wastewater incineration, thereby contributing to reduced CO2 emissions.

Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.

BrightCure Ltd. is a company based in London, United Kingdom, that specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). Founded in 2019, BrightCure addresses the significant challenge of recurrent and difficult-to-treat UTIs, which affect a large portion of the global population, particularly women. Conventional UTI treatments often fall short in effectiveness and can lead to serious side effects, contributing to the rise of antibiotic-resistant infections. The company focuses on leveraging the natural microbiome to eliminate harmful bacteria while restoring beneficial flora. BrightCure's flagship product, a bioactive intimate cream, is designed to enhance the natural immune response and support urinary tract health. The UTI treatment market is projected to grow significantly, reflecting the urgent need for effective solutions. BrightCure has received recognition for its innovative approach, including seed investment from SOSV and accolades in various competitions, underscoring its potential impact in the healthcare sector.

Gelatex is a materials technology company based in Estonia, founded in 2016 and incorporated in the UK in 2019. The company has developed a patented technology for producing bio-based nanofibers efficiently and cost-effectively, making it possible to produce these materials at a scale that is significantly faster and cheaper than traditional methods. Gelatex's production process utilizes gelatin derived from low-value waste in the meat and leather industries, ensuring that its products are made from natural and non-toxic substances, which promotes sustainability in the textile sector. Initially focused on creating eco-friendly leather-like textiles, the company pivoted during the COVID-19 pandemic to explore a broader range of applications for its nanofibers, including 3D scaffolds for tissue engineering, cultured meat, bio-based filters, energy storage, and wound care.

Plastogaz is a Swiss company based in Lausanne that specializes in producing natural gas from waste resources, specifically synthetic plastic waste. Founded in 2019, Plastogaz employs a patented catalyst technology to convert mixed plastics into grid-compatible methane and naphtha, which can be utilized as fuel or for creating new synthetic materials. This innovative approach not only facilitates the recycling of plastic waste but also aims to reduce greenhouse gas emissions associated with plastic disposal, contributing to a more sustainable environment.

Digi.Bio is a Netherlands-based company that specializes in developing software solutions for the healthcare industry, particularly in the field of cell therapies. It offers a microfluidic platform that automates repetitive and manual laboratory workflows, utilizing artificial intelligence and electrowetting technology to manipulate droplets at a microscale. This innovative approach aims to streamline multistep liquid handling applications, replacing traditional pipetting methods. Digi.Bio's platform delivers comprehensive analysis of cell therapies, evaluating their performance and outcomes at the single-cell level within 24 hours, while minimizing material waste. By enhancing automation in medical and pharmaceutical settings, Digi.Bio supports the advancement of bioengineering processes.

Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

Authena is a traceability solution provider headquartered in Zug, Switzerland, specializing in enhancing transparency across the supply chain through the integration of IoT devices, blockchain, and AI technologies. Its platform offers real-time, unit-level tracking and environmental condition monitoring, enabling industries such as Pharmaceuticals, Luxury, and Food and Beverage to safeguard brand reputation and consumer trust. Authena's notable products, Authena SHIELD™ and Authena L1VE, not only comply with regulatory standards but also foster consumer confidence through transparency and authenticity. The company is recognized for its commitment to sustainability and is the only traceability solution provider incorporated into NEOM's Oxagon accelerator, positioning itself as a leader in promoting a greener future. By protecting product identity against counterfeiting, diversion, and fraud, Authena helps brands achieve full visibility, improve financial performance, and enhance direct-to-consumer sales.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.

VAY is a computer vision company that specializes in digitizing human movements using simple camera technology. Founded in 2019 and based in Zurich, Switzerland, VAY's platform leverages artificial intelligence to enable precise perception and prediction of human motion. This innovative approach provides businesses with the ability to measure, analyze, and customize their products, enhancing outcomes across various applications, including health, sports, and gaming. VAY distinguishes itself with a system and hardware agnostic methodology, allowing for seamless integration into existing workflows. Their technology aims to create smarter, more interactive experiences by utilizing real-life data and feedback.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.

HUB85 is a business intelligence software solution which enables an organisation to identify, analyse and govern their internal spreadsheet environment. An organisation can get complete transparency on their spreadsheet inventory and can see real-time actionable insights to reduce risks, cut costs and improve operational efficiency across their enterprise. HUB85 has received a Founders Award from the Institute of Innovation and Entrepreneurship and has offices within the London Business School Incubator. HUB85 is also part of cohort 4 of the FCA Regulatory Sandbox.

Lyfegen is an independent provider of drug access, pricing, and rebate management solutions, with operations in Basel, Switzerland, and Boston, USA. The company specializes in helping healthcare payers and pharmaceutical companies establish appropriate pricing agreements for medications while efficiently managing drug rebates. Its platform is designed for the healthcare industry, assisting health insurance providers, pharmaceutical companies, MedTech firms, and hospitals worldwide in collecting, analyzing, and reconciling diverse healthcare data. This technology facilitates the automation of value-based healthcare contracting, ultimately aiming to enhance access to treatments, improve patient health outcomes, and increase affordability.

Naturbeads Ltd, established in 2018 and located in Malmesbury, United Kingdom, specializes in producing biodegradable cellulose microparticles designed to replace plastic microbeads commonly found in cosmetics, toiletries, and various industrial applications such as paints and adhesives. The company's innovative technology, developed at the University of Bath, offers an eco-friendly alternative that aims to mitigate the environmental impact of microplastic pollution in oceans and soil. By substituting fossil-fuel-based plastic with natural cellulose beads, Naturbeads enables its customers to adopt more sustainable practices and contribute to reducing pollution associated with conventional microbeads.

Readily3D is a Swiss company based in Lausanne, specializing in volumetric 3D printing solutions. Founded in 2020 as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL), the company has developed innovative printers capable of producing complex, patient-specific devices in under 30 seconds using tomography. Their technology utilizes a liquid photosensitive polymer, which is cured through dynamic light patterns from multiple angles, allowing for the creation of tailored orthoses for patients with hearing loss and surgical models for medical professionals. This approach not only enhances patient care but also streamlines surgical planning, positioning Readily3D as a leader in the advancement of personalized medical devices.

Hera - Mi is Specialized in digital medical imaging applied to breast cancer.Hera-MI has developed clinical decision support solutions to help improve early-stage breast cancer detection. Our solutions will improve the quality and accuracy of breast cancer diagnosis while decreasing radiologists’ interpretation time. Patients will be treated more quickly, offering them a better chance of remission. Hera-MI has developed Breast-SlimView, a clinical decision support software based on artificial intelligence and image processing for breast cancer diagnosis. Our partner, Fujifilm is selling Breast-SlimView in France and in the Overseas Territories of France (DROM/TOM). Breast-SlimView is also available for sale all over the world.

Exomotion SA, founded in 2018 and based in Plan-les-Ouates, Switzerland, specializes in the development of innovative personal mobility devices. The company's focus is on robotics-based transporter systems that facilitate omnidirectional movement. Exomotion's electronic movement devices integrate advanced electrical boards with motion sensors and a unique wheeled mechanism, allowing for seamless movement in any direction and immediate rotation. This design aims to enhance user experience by rethinking e-mobility, prioritizing both omnidirectionality and safety in its solutions.

Byteflies is a Belgian-American wearable health company focused on developing innovative health applications through advanced technology. With offices in Antwerp, Belgium, and the San Francisco Bay Area, the company is strategically positioned near major life sciences and clinical research centers as well as the heart of digital innovation. Byteflies specializes in a wearable component sensor dot that records various biopotential signals, muscle activity, eye movement, and activity-related signals using an integrated inertial measurement unit. This technology is designed to assist pharmaceutical companies, researchers, and technology firms in transforming healthcare and enhancing patient outcomes. Byteflies aims to revolutionize healthcare by meticulously monitoring vital signs and leveraging data-driven insights.

ALP Technologies is a renewable energy engineering start-up from London. It focuses on developing renewable energy technologies for the developing world. Since founding in 2015, it has won multiple awards and funded research and development projects such as advanced battery systems on recycled cells, novel biogas generation, and power electronic and control systems. Its small-scale power plant for developing regions uses solar, bio-ethanol, and agricultural waste to generate uninterrupted electricity. It aims to displace diesel generation and fossil fuel based power plants and leapfrog grid infrastructure in the developing world.

my110 is a London-based company that focuses on enhancing athlete performance through innovative health solutions. It has developed a tool designed to analyze and optimize body recovery, enabling athletes to achieve and maintain peak physical performance. The company also emphasizes a proactive approach to healthcare, utilizing decentralized methods for testing and tracking acute diseases. By integrating these strategies, my110 aims to improve overall health outcomes for athletes and individuals alike.

Amphasys is a technology company specializing in chip-based single-cell analysis technology that aims to simplify and expedite complex cell analyses, making them accessible at the point of use rather than solely in advanced laboratories. Founded in 2012 as a spin-off from Axetris AG, Amphasys developed its core technology in 2004 in collaboration with the Swiss Federal Institute of Technology Lausanne. Through extensive research across various cell types, it has demonstrated versatility for applications such as pollen and milk analysis. The technology streamlines processes by eliminating the need for time-consuming sample preparations, such as cell labeling, and reduces reliance on costly laboratory infrastructure. This enables clients to perform label-free analyses of single-cell characteristics, including cell size, morphology, viability, and differentiation. Amphasys has received recognition for its innovation, including the prestigious Swiss startup prize from the W.A. de Vigier Foundation in 2013.

Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.

moneyHOP is a digital cross-border banking platform that facilitates international payments and remittances through its web portal, HOPRemit, and mobile application, HOPApp. Based in London, UK, and Bangalore, India, the platform aims to simplify the process of money exchange for international travelers and individuals seeking remittance solutions. By offering a seamless, economical, and transparent way to conduct international money transfers, moneyHOP caters to the needs of both individuals and businesses, enhancing the convenience and speed of cross-border transactions.

FUL Foods is a Netherlands-based startup dedicated to creating food and beverage products that positively impact the environment by reducing carbon emissions and conserving resources. The company has developed a proprietary carbon-negative ingredient derived from microalgae, known as FUL, which addresses challenges related to taste and solubility. FUL Foods offers a range of sustainable and nutritious beverages, with its flagship product being a refreshing drink that combines natural nutrition, plant-based protein, and immune-boosting properties. The company's mission emphasizes superior health benefits, convenience, and overall satisfaction for consumers while promoting a planet-positive approach to food and beverage production.

Agrolabs Limited specializes in developing sensor telemetry solutions aimed at enhancing the productivity of horticultural farmers. Established in 2017 and headquartered in London, with additional offices in Hong Kong and Dnipro, Ukraine, the company offers innovative products such as Agrolabs W-Sens, which provides real-time analytics on indoor crop growth performance, and Agrolabs B-Control, designed for automated pollination control and bee activity monitoring. By leveraging cloud-based Internet of Things (IoT) technology, robotics, and artificial intelligence, Agrolabs facilitates data-driven insights that empower greenhouse farmers to manage irrigation, pollination, and environmental conditions more effectively. This approach aims to boost crop yields and improve overall efficiency in the growing process.

TrucksOnTheMap Limited is a digital freight brokerage platform that specializes in providing software solutions for truck and freight management. Established in 2015 and based in London, the company offers a software as a service (SaaS) platform that includes features such as truckload allocation, bidding, process analysis, job allotment, and real-time truck tracking. The software enables trucking professionals to visualize truck availability, request quotations, and optimize freight logistics, thereby turning empty freight runs into profitable opportunities. By focusing on technology-driven solutions, TrucksOnTheMap aims to enhance efficiency in the transportation and supply chain sectors.

TechnoCarbon is a France-based startup focused on developing innovative, low-carbon-footprint materials aimed at transforming the architecture and industrial sectors. The company has introduced CarbonFibreStone™ (CFS™), a high-performance composite designed to replace traditional materials such as reinforced concrete, steel, and aluminum, which are known for their environmental impact. By utilizing a patented technology, TechnoCarbon creates a new family of materials that not only meet the technical demands of construction but also promote energy efficiency and resource conservation. CFS™ is suitable for a wide range of applications, including construction, infrastructure, aerospace, defense, luxury goods, furniture, and high-fidelity audio, positioning TechnoCarbon as a key player in the push for sustainable building practices.

IBISA is an index-based insurance marketplace founded in 2018 and based in Luxembourg. The company leverages blockchain technology and satellite earth observation data to offer innovative risk modeling services. Its platform focuses on providing affordable crop protection solutions for smallholder farmers through a mutual risk-sharing approach. This model enables quick assessment and payment processes, ensuring that farmers receive timely support in times of need. By combining advanced technology with a commitment to inclusivity, IBISA aims to enhance the financial resilience of agricultural communities.

Aeropowder Ltd is a London-based company established in 2016 that focuses on developing and manufacturing sustainable materials derived from poultry feather waste. By creating a new value chain from the approximately 10 million tons of surplus feathers produced annually, Aeropowder aims to contribute to the circular economy. Its primary product, Pluumo, is an innovative thermal packaging material designed to outperform traditional expanded polystyrene in temperature-sensitive deliveries, such as food and pharmaceuticals. Made from keratin proteins, Aeropowder's insulated feathers are not only water-repellent but also provide thermal and acoustic insulation, making them an environmentally friendly alternative to conventional packaging materials. The company strives to enable local production of high-performance materials wherever feather waste is available.

Smeetz SA is an online booking platform based in Lausanne, Switzerland, that specializes in the leisure and entertainment industry. Founded in 2016, the company offers a comprehensive suite of solutions designed to streamline event organization and promotion. Its platform incorporates AI-powered tools for sales, marketing, reservation management, ticket booking, and distribution. Smeetz employs dynamic pricing strategies and data analytics to help venues optimize revenue and enhance operational efficiency. The platform also includes features such as a booking widget, cross-channel sales, access control, payment methods, and customizable ticket solutions. By unifying commerce and embedding financial tools, Smeetz aims to transform the customer experience in the leisure sector, enabling businesses to thrive in a competitive environment.

C2C NewCap, founded in 2014 by Rui Silva and Andre Mao de Ferro, is a Lisbon-based manufacturer specializing in the production of supercapacitors designed for efficient electrical energy storage. The company focuses on developing next-generation devices that utilize proprietary electrodes and an aqueous electrolyte, which contribute to a low environmental impact. C2C NewCap aims to provide clients with energy storage solutions that not only enhance operational efficiency but also reduce overall environmental and operational costs.

Hi-D Imaging AG, founded in 2019 and based in Winterthur, Switzerland, specializes in a SaaS-based pre-operational planning platform tailored for cardiac procedures, particularly trans-catheter aortic valve implantation. The platform assesses the hemodynamics of patient-specific anatomies, allowing physicians to analyze blood flow patterns and perform in-vitro fluid dynamic analyses. This technology enables the selection of the optimal size and shape of heart valves, facilitating personalized solutions for patients with aortic stenosis before cardiac surgery. By streamlining pre-operational planning and enhancing data-driven decision-making, Hi-D Imaging aims to improve outcomes for patients with cardiovascular diseases while reducing the need for unnecessary medical imaging examinations. The company's AI-based cardiac image processing technology further supports medical professionals by producing detailed images of cardiac structures, thereby decreasing planning times and addressing the limitations of traditional medical scans.

Semantic Evolution, based in London with an office in New York, specializes in artificial intelligence and Intelligent Data Extraction. The company addresses the challenges businesses face in managing unstructured data, which constitutes approximately 80% of all information and is often difficult to access. By utilizing proprietary machine learning, advanced semantics, and natural language processing, Semantic Evolution's technology automates the extraction of critical data from unstructured documents, transforming it into actionable information. This approach allows clients, particularly in the finance industry, to visualize, normalize, and validate data efficiently. As a result, companies that implement Semantic Evolution's solutions benefit from enhanced operational efficiencies, improved data quality, and reduced processing times, ultimately achieving rapid returns on investment while freeing up resources and cutting costs.

Automation Hero, Inc. specializes in developing artificial intelligence-driven applications to automate sales processes and enhance business efficiency. The company offers a range of tools, including Viz Studio, which enables users to visualize and optimize complex processes; Hero_Go, a screen automation recorder for data extraction and input; and Flow Studio, designed for developers to create tailored solutions. Additionally, Automation Hero provides AI Studio, which addresses limitations in traditional robotic process automation, and domain-intelligent optical character recognition (OCR) technology that digitizes various document types. The company's application, Robin, assists in generating new accounts and leads while streamlining meeting scheduling. Catering to diverse industries such as insurance, banking, technology, retail, manufacturing, telecommunications, and media, Automation Hero aims to improve operational efficiency and reduce repetitive tasks. Founded in 2017 and headquartered in San Francisco, California, the company also has offices in Berlin and Halle, Germany. Formerly known as SalesHero, Inc., it rebranded as Automation Hero, Inc. in March 2019.

Byteflies is a Belgian-American wearable health company focused on developing innovative health applications through advanced technology. With offices in Antwerp, Belgium, and the San Francisco Bay Area, the company is strategically positioned near major life sciences and clinical research centers as well as the heart of digital innovation. Byteflies specializes in a wearable component sensor dot that records various biopotential signals, muscle activity, eye movement, and activity-related signals using an integrated inertial measurement unit. This technology is designed to assist pharmaceutical companies, researchers, and technology firms in transforming healthcare and enhancing patient outcomes. Byteflies aims to revolutionize healthcare by meticulously monitoring vital signs and leveraging data-driven insights.

CogniCor Technologies S.L. is a Barcelona-based company founded in 2012 that specializes in automated complaint resolution services and artificial intelligence solutions. Its offerings include iComplaint, which integrates with websites to address customer complaints; iResolve, which directly resolves these complaints; iMediate, designed to settle claims and retain clients through counter offers; and iReport, aimed at identifying and addressing the root causes of complaints to prevent future issues. Additionally, CogniCor develops advanced AI platforms and digital assistants to improve operational efficiency and customer service for wealth management firms, insurance companies, and financial advisors.

CogniCor Technologies S.L. is a Barcelona-based company founded in 2012 that specializes in automated complaint resolution services and artificial intelligence solutions. Its offerings include iComplaint, which integrates with websites to address customer complaints; iResolve, which directly resolves these complaints; iMediate, designed to settle claims and retain clients through counter offers; and iReport, aimed at identifying and addressing the root causes of complaints to prevent future issues. Additionally, CogniCor develops advanced AI platforms and digital assistants to improve operational efficiency and customer service for wealth management firms, insurance companies, and financial advisors.

Semantic Evolution, based in London with an office in New York, specializes in artificial intelligence and Intelligent Data Extraction. The company addresses the challenges businesses face in managing unstructured data, which constitutes approximately 80% of all information and is often difficult to access. By utilizing proprietary machine learning, advanced semantics, and natural language processing, Semantic Evolution's technology automates the extraction of critical data from unstructured documents, transforming it into actionable information. This approach allows clients, particularly in the finance industry, to visualize, normalize, and validate data efficiently. As a result, companies that implement Semantic Evolution's solutions benefit from enhanced operational efficiencies, improved data quality, and reduced processing times, ultimately achieving rapid returns on investment while freeing up resources and cutting costs.

CellSpring is a biotechnology company based in Zurich, Switzerland, focused on enhancing cell-based in vitro studies through innovative technology. Its flagship platform, 3D Bloom, allows for the rapid creation of biomimetic microtissues that are independent of cell type. This platform significantly improves upon traditional 3D cell culture methods by offering faster fabrication, greater reliability, and enhanced versatility. The microtissues developed using 3D Bloom are designed to serve various biological functions, including aiding clinicians in the early diagnosis of cancer. Through its advancements, CellSpring aims to facilitate fundamental improvements in the field of biotechnology and medical research.

Enterprise Bot GmbH is a company that specializes in developing artificial intelligence-driven chatbots aimed at automating customer interactions for enterprises. Founded in 2017 and headquartered in Zug, Switzerland, with an additional office in Bengaluru, India, the company offers a range of products, including chatbots for sales and customer service, email triage bots, and scheduling assistants. Its solutions are particularly beneficial for financial institutions and insurance companies, providing a multi-platform messenger that addresses various customer needs and queries. By implementing these chatbots, enterprises can significantly reduce operational costs and customer wait times, enhancing the overall customer experience.

PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Planted Foods AG, founded in 2019 and based in Zürich, Switzerland, specializes in the development of plant-based meat products. The company's offerings include planted chicken and BBQ planted chicken, which are crafted using pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. By employing advanced technology, Planted Foods transforms these natural ingredients into nutritious, high-protein alternatives that appeal to consumers seeking plant-based options. Additionally, the company operates an e-commerce platform to facilitate the sale of its products directly to customers.

iWin, based in Manno, Switzerland, specializes in the development of an innovative photovoltaic venetian-blind shading device that is seamlessly integrated into insulating windows without affecting their design or functionality. Established in 2019, the company aims to enhance building sustainability, as the construction sector is responsible for approximately 40% of global CO2 emissions. The patented system not only generates renewable energy on-site but also effectively controls light and solar radiation, protecting buildings from overheating in summer. iWin’s product is customizable in size and color, durable, and requires minimal maintenance, boasting a payback period of less than ten years. The company has created its first working prototype and has formed partnerships with SUPSI and Pellini Group, a leader in integral venetian blinds. With a significant market opportunity, particularly in Switzerland where around 900,000 square meters of glass façades are installed annually, iWin is poised for growth in the sustainable building sector.

Watttron GmbH, founded in 2016 and based in Freital, Germany, specializes in the development of innovative heating systems that ensure precise temperature control and efficient energy management across various industrial applications. The company offers a range of products, including matrix heating and sealing heat systems, as well as customized heating solutions and simulation services. Watttron's advanced technology enables heterogeneous heating of surfaces, making it superior to traditional heating methods. Its systems are utilized in diverse sectors such as polymer processing, packaging, additive manufacturing, chemistry, microelectronics, biotechnology, automotive, and medicine, allowing for the effective processing of bio-based and recycled materials.

OxyPrem AG is a Swiss company that specializes in developing and manufacturing sensor solutions for monitoring preterm infants. Founded in 2018 and based in Zurich, OxyPrem offers an advanced reusable oxygen sensor that continuously measures brain oxygen levels in high-risk preterm infants using noninvasive near-infrared light technology. This device accurately determines hemoglobin oxygen saturation in any human tissue, allowing healthcare providers to deliver improved clinical care while significantly reducing waste. By enabling real-time monitoring, OxyPrem's technology plays a crucial role in preventing early death and mitigating the risk of severe long-term brain damage in this vulnerable population.

Terapet SA, founded in 2019 in Geneva, Switzerland, specializes in proton therapy, an advanced form of radiotherapy for cancer treatment. Established by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals, the company aims to provide precise tumor targeting while minimizing damage to adjacent healthy tissues. Terapet's innovative technology allows for a reduced radiation dose to surrounding healthy cells by administering high doses of protons that halt at specific depths within the patient. This capability enables medical professionals to monitor the proton dose in real-time and in three dimensions, making cancer treatment more effective and potentially more cost-efficient. The company has successfully demonstrated the feasibility of its concept and is in the process of developing an initial version for market launch.

Logmind Ltd is a company based in Lausanne, Switzerland, that specializes in developing an AI-accelerated data analytics platform focused on unstructured log data. Founded in 2018, Logmind’s platform provides visibility and automated insights, enabling organizations to effectively analyze the vast amounts of log data generated by complex IT infrastructures. The platform is designed to assist IT operations and DevOps teams by automatically detecting application issues, thereby helping clients maintain bug-free applications and proactively avoid costly incidents. Key features include real-time error detection, visual dashboards, notifications, and structured insights that transform unorganized datasets into actionable operational intelligence.

Plair SA specializes in the development and manufacturing of advanced systems for monitoring environmental conditions, particularly focusing on airborne particles. Founded in 2014 and based in Geneva, Switzerland, the company offers a range of innovative instruments, including the Particle Analyzer PA-300, which provides real-time detection, identification, and classification of fine particles in the air. This device can differentiate various entities such as pollen species, organic particles like fungal spores, and pollutants including polycyclic aromatic hydrocarbons. Additionally, Plair SA's Rapid-E and Rapid-C instruments utilize cutting-edge technologies like laser-induced fluorescence and light scattering for comprehensive analysis of aerosol particles. The company's solutions cater to applications in airborne allergen monitoring, air quality assessment, and bioaerosol analysis, enabling a deeper understanding of atmospheric aerosol concentrations. Plair SA is a spin-off from the University of Geneva, reflecting its strong academic foundation.

Hempfy is a Swiss company specializing in the production of innovative, THC-free hemp-infused food and beverages. Utilizing proprietary cold infusion technology, Hempfy cultivates, harvests, and processes hemp plants in compliance with Swiss legislation. All products are 100% Swiss-made, with a focus on bespoke quality, from seed selection to final production. Hempfy aims to replace smoking and alcohol as the world's preferred social drug, offering cannabis-based products with a balanced taste and light carbonation.

BCRemit, headquartered in London, is a fintech company specializing in global money transfers. It facilitates online transfers via web, app, and call center, focusing on providing competitive fees and favorable exchange rates to migrant workers worldwide.

Clemedi AG develops innovative diagnostic workflows for infectious diseases, focusing on in vitro diagnostic tests that leverage next-generation sequencing and machine learning technologies. Established in 2018 and headquartered in Schlieren, Switzerland, the company aims to combat antibiotic resistance, which is projected to cause 10 million deaths annually by 2050. Clemedi's test kits are designed to diagnose drug-resistant infections directly from patient samples within a day, thereby enhancing doctors' decision-making and facilitating timely, personalized antibiotic therapies. By providing comprehensive information for targeted treatment, Clemedi strives to reduce antibiotic consumption and slow the spread of resistance, ultimately benefiting patients suffering from infectious diseases.

CrystalsFirst GmbH specializes in protein crystal stabilization techniques to enhance drug candidate screening, primarily serving pharmaceutical companies. Founded in 2018 and based in Marburg, Germany, the company offers innovative solutions such as SmartSoak technology for screening small molecule arrays, SmartLib for fragment-based drug discovery, and SmartRefine for automated crystallographic data refinement. Their MAGNET platform represents a significant advancement in drug discovery, integrating high-performance structural biology with generative AI and machine learning to identify novel molecules and druggable binding sites. By employing a "crystal structure first" approach, CrystalsFirst facilitates rational drug design and provides valuable insights into target interactions. The company's methodologies enable rapid access to diverse chemical scaffolds, thereby accelerating the discovery of effective therapeutic compounds and enhancing the overall efficiency of the drug development process.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Topl is a company that specializes in blockchain infrastructure aimed at enabling businesses and communities to monetize their ethical and sustainable practices. Founded in 2017 and based in both Maastricht, Netherlands, and Houston, Texas, Topl offers blockchain-as-a-service solutions tailored for supply chain management and certification. Its primary product, the Topl Blockchain, serves as a protocol designed specifically for the impact sector, allowing organizations to verify and monetize their positive contributions. In addition to the blockchain, Topl provides a suite of hosted services and tools that facilitate user interaction with its technology, supporting projects across various industries and borders. Overall, Topl seeks to empower companies to transform their social and environmental impact into tangible assets.

Dronistics, based in Lausanne, Switzerland, specializes in developing a personal drone delivery system designed for last-centimeter delivery to hard-to-reach locations. The company's drones operate autonomously, utilizing GPS technology and a web application that can be accessed from various devices, including smartphones, tablets, and laptops. Each delivery is facilitated through a 4G internet connection, ensuring seamless control and communication. Dronistics emphasizes safety in its operations, incorporating multiple safety checks to protect individuals during the flight and delivery process. This innovative approach enables logistics and online retail companies to effectively address delivery challenges in remote areas.

Regenosca SA is a Swiss company based in Lausanne that specializes in the development and commercialization of medical implants designed for bladder reconstruction. Founded in 2019, the company offers sterile, off-the-shelf implants that serve as alternatives to autologous tissue substitutes for soft tissue repair. These innovative biomaterials aim to enhance bladder preservation and minimize scarring, ultimately improving patients' quality of life. By focusing on easy-to-use medical devices, Regenosca is committed to advancing surgical practices and patient outcomes in bladder-related procedures.

Authena is a traceability solution provider headquartered in Zug, Switzerland, specializing in enhancing transparency across the supply chain through the integration of IoT devices, blockchain, and AI technologies. Its platform offers real-time, unit-level tracking and environmental condition monitoring, enabling industries such as Pharmaceuticals, Luxury, and Food and Beverage to safeguard brand reputation and consumer trust. Authena's notable products, Authena SHIELD™ and Authena L1VE, not only comply with regulatory standards but also foster consumer confidence through transparency and authenticity. The company is recognized for its commitment to sustainability and is the only traceability solution provider incorporated into NEOM's Oxagon accelerator, positioning itself as a leader in promoting a greener future. By protecting product identity against counterfeiting, diversion, and fraud, Authena helps brands achieve full visibility, improve financial performance, and enhance direct-to-consumer sales.

Topl is a company that specializes in blockchain infrastructure aimed at enabling businesses and communities to monetize their ethical and sustainable practices. Founded in 2017 and based in both Maastricht, Netherlands, and Houston, Texas, Topl offers blockchain-as-a-service solutions tailored for supply chain management and certification. Its primary product, the Topl Blockchain, serves as a protocol designed specifically for the impact sector, allowing organizations to verify and monetize their positive contributions. In addition to the blockchain, Topl provides a suite of hosted services and tools that facilitate user interaction with its technology, supporting projects across various industries and borders. Overall, Topl seeks to empower companies to transform their social and environmental impact into tangible assets.

Biospectal is a company focused on remote patient monitoring and biosensing, having developed the OptiBP smartphone app and data platform for blood pressure measurement. This innovative app allows users to measure their blood pressure using the built-in camera of a smartphone, capturing blood flow through the fingertip in a quick and easy manner. The measurement process takes approximately 20 seconds, which is significantly faster than traditional blood pressure cuffs. Biospectal’s proprietary algorithms analyze the optical signals captured by the camera to provide accurate blood pressure readings. Currently, the public beta of the OptiBP app for Android is available in several countries, including the United States, the United Kingdom, France, Germany, Spain, and Switzerland. This technology empowers individuals to monitor their blood pressure anytime and anywhere, transforming smartphones into medical-grade devices without the need for additional peripherals.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

Prodibi is a professional image platform that enhances the online display of images to boost brand ROI, improve user engagement, and streamline the work of developers. Launched in 2011 and based in Geneva, Switzerland, the platform addresses common challenges in image quality, performance, color management, pixel density, responsiveness, and SEO, which can be costly and time-consuming to resolve. For example, tasks like cropping images can take significant time for graphic designers. Prodibi simplifies this process by allowing users to replace online images with a single click, ensuring an exceptional visual experience that aligns with brand prestige. The subscription-based service enables photographers, professional artists, and web publishers to showcase their work effectively on both web and mobile platforms without sacrificing speed or quality.

BASF, established in 1865, is the world's largest chemical company, operating globally with a top-three market position in approximately 70% of its businesses. Its portfolio spans the full chemical spectrum, from commodities to specialties, including agricultural chemicals and emissions control catalysts. BASF Venture Capital, founded in 2001, is the company's corporate venture capital arm. It invests worldwide in promising startups and funds relevant to BASF's current and future business fields, focusing on innovations in chemistry, new materials, sustainability, digitization, and new business models. The firm supports its portfolio companies by leveraging BASF's global research, partnership, and customer networks. BASF Venture Capital is headquartered in Ludwigshafen, Germany, with additional offices in San Francisco, Boston, Shanghai, Sao Paulo, and Tel Aviv.

Securaxis specializes in the development, installation, and operation of innovative safety and security solutions. Founded in 2018 as the first incubated company of BIC of CERN Technologies in Switzerland, Securaxis has garnered recognition through various accolades, including the Entreprendre Network and Swisscom Start-up Challenge. The company is part of the HP Enterprise Startup Incubator and the NVIDIA Inception Program. Securaxis has a dedicated team of eight experts in fields such as machine learning, acoustics, and data management, who have collaborated for over four years. They have successfully developed and commercialized a mobile security application utilized by clients including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations. Securaxis operates a real-time geolocalized security information platform that employs smart acoustic sensors to analyze and classify sounds in urban environments, enabling organizations to make informed decisions to enhance safety.

Akselos S.A. is a Switzerland-based company that develops Integra, a cloud-based engineering simulation software designed for asset-centric industries such as oil and gas and offshore wind. Founded in 2011, Akselos enables engineers to create high-resolution simulations of large-scale operational assets through its advanced digital twin technology. The Integra platform allows users to build detailed 3D models, adjust various parameters, perform hydrodynamic analysis, and evaluate the structural integrity of fixed offshore assets and other critical infrastructure. With patented algorithms that enhance simulation speed and accuracy, Akselos aims to support preventative maintenance and reduce unplanned downtime by providing real-time insights into asset conditions. The company operates in various regions, including Europe, the USA, and Southeast Asia, and maintains a subsidiary in Cambridge, Massachusetts.

Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Bloom Biorenewables Ltd is a Swiss company founded in 2019, focused on developing technology that transforms wood and agricultural waste into renewable materials as alternatives to petroleum. The company specializes in creating bio-based materials for the chemical industry, targeting various markets including fragrances, plastics, and textiles. By introducing innovative production methods for biorenewable products and fuels, Bloom Biorenewables aims to provide sustainable solutions that reduce reliance on fossil fuels and contribute to climate change mitigation.

Rapid Graft is a medical device company founded in 2018 and based in Zurich, Switzerland. The company specializes in developing an innovative dermatome designed to facilitate the precise and rapid harvesting of small split-skin grafts. This technology aims to enhance the treatment of chronic wound patients and address future needs in tissue engineering. The device enables surgeons to perform skin grafting procedures with minimal discomfort, eliminating the need for specialist intervention or an operating room. Additionally, it reduces the risk of infection and scarring, promoting faster skin cell regeneration and improved healing outcomes for patients.

ALAnostics is a biopharmaceutical company that specializes in oncodiagnostics, originating as a spin-off from the University of Geneva. The company focuses on developing innovative tumour painting technology designed to assist surgeons in the real-time identification and removal of breast cancer during surgery. By utilizing nanomedicines for fluorescence-guided surgery, along with 5-ALA prodrugs for photodynamic therapy and light-activated antimicrobials, ALAnostics aims to enhance the accuracy of tumor removal, ultimately improving patient outcomes and saving lives.

Intelistyle Ltd. is a London-based artificial intelligence fashion stylist company founded in 2017. It specializes in providing personalized styling recommendations for fashion retailers, enhancing their digital discovery experiences. Its platform includes features such as "Complete the Look," which generates multiple outfit combinations for selected products, and an AI chatbot that offers personal styling advice. Additionally, it provides alternatives for out-of-stock items and assists in wardrobe management. Intelistyle is utilized by prominent brands, including D&G, MaxMara, and Tommy Hilfiger, to improve customer engagement and sales. The platform's unique fashion-specific personalization capabilities have demonstrated superior performance compared to human stylists, generating a significant revenue uplift for retailers and increasing conversion rates, basket sizes, and repeat purchases.

Flyla GmbH, founded in 2018 and based in Munich, Germany, specializes in online booking solutions tailored for students and young travelers. The company connects with airlines to establish student fares as part of a revenue management strategy, distributing these discounted rates to its growing network of enrolled university students. By offering an intuitive online platform, Flyla simplifies travel arrangements, allowing users to easily access deals, provide necessary travel details, and complete payments. This approach aims to address the financial barriers faced by students, making air travel more accessible and affordable.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Kejako SA is a Swiss company specializing in the research and development of medical devices for the ophthalmic surgery sector, specifically targeting presbyopia. Founded in 2015 and headquartered in Plan-les-Ouates, Switzerland, Kejako aims to provide a non-invasive solution for patients experiencing a decline in visual accommodation due to age-related changes. The company employs a unique approach that combines simulation with minimally invasive treatments, utilizing a full eye 3D parametric model alongside multi-physics numerical modeling to assess the eye's optical and mechanical behavior. This innovation enables patients to better plan and control their customized procedures, ultimately enhancing their quality of life as they manage the effects of presbyopia.

Aesyra SA, founded in 2017 and based in Lausanne, Switzerland, specializes in the design and manufacture of medical devices focused on managing sleep disorders. The company's flagship product, AesyBite, is an intra-oral sensor that monitors and alleviates sleep bruxism, a condition characterized by teeth grinding during sleep. Aesyra's technology enables dental professionals to conduct intraoral measurements while patients sleep, allowing for the detection of bruxism and other sleep-related issues, such as obstructive sleep apnea. By providing accurate monitoring and biofeedback alternatives, Aesyra aims to help healthcare providers reduce damage to dental prostheses caused by occlusal problems and improve overall sleep quality for their patients.

LIfT BioSciences is a biotechnology company based in London, England, founded in 2016. The company specializes in a novel allogeneic innate immuno-cell therapy platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). This platform enables the large-scale production of Immunomodulatory Alpha Neutrophils (IMANs) derived from induced pluripotent stem cells (iPSCs) for various therapeutic applications. LIfT BioSciences focuses on developing CAR neutrophil cell therapies that address the limitations of existing treatments for solid tumors. These therapies work by directly attacking tumors and indirectly enhancing the immune response, effectively transforming the tumor microenvironment to recruit additional immune cells for a more robust and lasting attack on the cancer. By employing proprietary enhancement media and genetic engineering, LIfT BioSciences aims to significantly increase the cancer-fighting capabilities of these engineered cells, potentially providing patients with greatly improved therapeutic outcomes.

Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

Onto Ltd is a UK-based company that specializes in electric vehicle subscription services, allowing customers to drive electric cars without the long-term commitment of ownership. Founded in 2017 in Warwick by Rob Jolly and Dannan O’Meachair, Onto offers an all-inclusive package that covers various aspects of vehicle usage, including insurance, breakdown cover, maintenance, charging solutions, and road tax. This hassle-free model enables users to easily access vehicles from depots by paying a single subscription fee that encompasses all related costs, facilitating a seamless transition to electric driving. The company, formerly known as EVezy, rebranded to Onto Ltd in July 2020 and operates from Birmingham.

Lab-on-Fiber GmbH, based in Halle, Germany, specializes in the development and production of advanced medical laser probes and systems aimed at enhancing minimally invasive surgical procedures. The company offers a range of fiber delivery systems, including surgical and urology fiber probes. By providing optimized radiation profiles and real-time temperature monitoring at the probe surface, Lab-on-Fiber's technology helps surgeons reduce operating times, improve treatment outcomes, and enhance patient safety. Their innovative solutions are designed to streamline laser surgery while minimizing potential complications, positioning Lab-on-Fiber as a key player in the medical technology sector.

Heepsy is an influencer marketing platform that facilitates connections between agencies, brands, and influencers. Founded in 2016 and headquartered in Bilbao, Spain, the company provides tools for businesses to discover Instagram influencers tailored to specific campaign themes, locations, follower counts, and engagement rates. This enables brands to identify authentic influencers who align with their marketing goals and enhance the effectiveness of their campaigns. By streamlining the search process, Heepsy empowers brands to make informed decisions in their influencer partnerships.

Parquery AG, founded in 2014 and based in Zurich, Switzerland, specializes in smart parking solutions through the development of a web application that provides real-time on-street parking availability. The company employs computer vision and machine learning technologies to analyze images and detect parking vacancies, utilizing snapshots from existing cameras to deliver accurate data. This service caters to parking managers and supports smart city and mobility initiatives by offering insights into past, current, and predicted future usage of parking facilities, thereby facilitating smarter routing options for drivers seeking available parking spots.

Letos is a computer software startup founded in 2016 and headquartered in Brandenburg, Germany. The company specializes in behavioral sciences, affective neuroscience, and well-being technologies. Letos develops machine learning technology that predicts user behavioral reactions by utilizing biosensors and advanced machine learning techniques. This platform captures genuine spontaneous emotional responses, allowing organizations to assess user satisfaction, alertness, and overall well-being while ensuring user anonymity. By placing the human user at the center of its innovations, Letos aims to enhance the understanding of user experiences in various applications.

GliaPharm SA is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders. Founded in 2016 and based in Geneva, the company utilizes its GliaX technology platform to identify drugs that target the activity of glial cells, which are essential support cells for neurons. This innovative approach aims to enhance brain metabolism in pathological conditions. GliaPharm employs high throughput screening technologies and conducts metabolic tests on both in vitro primary brain cell cultures and in vivo rodent models to evaluate compounds. The company addresses various neurological conditions, including Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and collaborates with contract research organizations to advance its drug development and regulatory processes. With a vision to lead in glia-mediated therapies, GliaPharm seeks to provide new neuroprotective agents that support cognitive function in patients.

MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.

Alogo Analysis SA, based in Apples, Switzerland, specializes in developing advanced analytics tools for the equine industry, particularly focusing on equestrian sports like show-jumping. Founded in 2016, the company aims to modernize the discipline by providing innovative solutions that quantify athlete performance. Its flagship product, Move, allows users to assess horse performance and monitor health and locomotion through a web application that displays comprehensive data. By offering novel performance statistics, Alogo Analysis SA seeks to enhance understanding of equestrian sports, improve spectator experience, and increase fan engagement, thus contributing to the evolution of the sport at both training and competition levels.

RiskTalk Ltd is a developer of a communication tool aimed at enhancing employee engagement regarding issues that impact core organizational values. Founded in 2016 and headquartered in Lausanne, Switzerland, with an additional office in Kent, United Kingdom, RiskTalk enables a bottom-up communication approach, allowing employees to report concerns without fear of bias or reprisal. The tool facilitates the identification and logging of risks, turning discussions into actionable items by assigning responsibilities to appropriate personnel and providing feedback mechanisms. This innovative approach aims to create a blame-free environment for addressing risks, thereby improving overall organizational responsiveness and accountability.

Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.

BAABUK is a Swiss company founded in 2013 by a dynamic couple, Galina and Dan. Their story began when Galina's parents gave Dan a pair of traditional Russian "Valenkis". In the past, these Russian felted boots were essential to fight the Siberian cold. So after trying them out in the snow, Galina and Dan had an idea! Why not preserve the "Valenki" ancestral know-how and create a revised pair of 100% wool shoes? That's when the first BAABUK pair of shoes was born, and they didn't stop there...

Skypull SA is a Swiss company founded in 2013, focused on developing an airborne wind energy system that utilizes a hybrid drone capable of vertical take-off and landing. This drone operates at higher altitudes, where it captures energy from strong and consistent winds through a tether connected to a ground-based generator, thereby generating electricity. Skypull's proprietary airframe design enhances the drone's efficiency and versatility, setting it apart from competitors. The company's technology aims to provide an affordable and clean energy solution that contributes to climate change mitigation by facilitating the transition from fossil fuels to renewable energy sources.

GuestLee is a Swiss Property Management company. In a exponentially growing market GuestLee positioning settled naturally by trust & recommendation to high-end property owners. 90% of their customers are seniors that worked hard to build real estate assets. With today’s versatile economical environment, living on savings or limited pension allowances, it is quite difficult to sustain life standards as well as to pay property maintenance fees. GuestLee is a decentralized business model using latest technologies to help seniors to generate revenue

MEMBRASENZ GmbH was founded in June 2015 by Dr. Jelena Stojadinovic and Prof. Dr. Fabio La Mantia. The company's mission is to supply innovative gas separator solutions for electrolyzers’ industry and make hydrogen universally accessible. Moreover, MEMBRASENZ’s vision is to be the supplier of resource supporting products enabling the sustainability of sense and integrity based energy systems. The company is a spin-off of the Center for Electrochemical Sciences at the Ruhr-University Bochum. MEMBRASENZ has been supported by German Ministry of Economy and Energy BMWi (EXIST grant), Cluster of Excellence RESOLV "Ruhr Explores Solvation" and Horizon 2020 EU Framework Programme for Research and Innovation.

LEDsafari SA, founded in 2014 and based in Lausanne, Switzerland, focuses on sustainability education through innovative training programs and solar kits. The company aims to empower future generations to address climate change by providing hands-on learning experiences in schools and educational institutions. Its flagship product is a solar kit that enables users to assemble an electrical circuit and create a lamp from recycled materials. This approach not only teaches solar technology theories but also promotes eco-friendly practices. LEDsafari has successfully sold 15,000 solar kits across 15 countries via its online platform. The company is also developing a state-of-the-art learning platform featuring high-quality animations, graphics, and games, with plans to incorporate augmented reality and mobile technology in the future.